Get started

Stocksignals

TESLA Huge Inverse Head & Shoulders ahead of Musk's $56B vote!Tesla (TSLA) broke today above its 1D MA100 (green trend-line) for the first time in more than 5 months (since January 04) and ahead of Musk's $56 billion today, seems to be completing an Inverse Head and Shoulders (IH&S) pattern. Technically this is a pattern seen in major market bottom's. This time it is being formed within the broader pattern of the Bearish Megaphone. A standard 2.0 Fibonacci extension Target would test the top (Lower Highs trend-line) of that Megaphone, considerably above the 1D MA200 (orange trend-line). As a result, our medium-term Target is $225.00, marginally below the 2.0 Fibonacci extension. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NASDAQ:TSLALong
by TradingShot
Meghmani on the verge of breakout mega breakout?Meghmani Organics Ltd. operates as a diversified chemical company. It operates under the following segments: Pigment segment and Agrochemical segment. Meghmani Organics CMP is 83.21. The positive aspects of the company are Company with Zero Promoter Pledge, Growth in Net Profit with increasing Profit Margin (QoQ), Stock with Low PE (PE = -20) and FII / FPI or Institutions increasing their shareholding. The Negative aspects of the company are Degrowth in Revenue and Profit, Companies not able to generate net cash and Annual net profit declining for last 2 years. Entry can be taken after closing above 84.5. Targets in the stock will be 93 and 96. The long-term target in the stock will be 100 and 105. Stop loss in the stock should be maintained at Closing below 71. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:MOLLong
by Happy_Candles_Investment
BEPL giving a breakout on bounce. Bhansali Engineering Polymers Ltd. engages in the manufacture and sale of acrylonitrile butadiene styrene (ABS) and styrene acrylonitrile (SAN) resins. Bhansali Engineering Polymers CMP is 99.68. The positive aspects of the company are Company with No Debt, Company with Zero Promoter Pledge, Growth in Operating Profit with increase in operating margins (YoY) and MFs increased their shareholding last quarter. The Negative aspects of the company are Companies not able to generate net cash. Entry can be taken after closing above 100. Targets in the stock will be 103, 106 and 109. The long-term target in the stock will be 113 and 117. Stop loss in the stock should be maintained at Closing below 88. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:BEPLLong
by Happy_Candles_Investment
🗺️NVIDIA Roadmap🗺️🚀➕20%🚀🔔Today, I want to analyze NVIDIA stock for you because I think it still has the potential to increase in price, and also, in NVIDIA 's previous rally, AI tokens had a good rise. 💡The main reason for Nvidia's growth is the company's leadership in the field of Artificial Intelligence(AI) chips . The market value of this company crossed the one trillion dollar mark less than a year ago. Nvidia now has a higher market value than the well-known companies Amazon and Google . 💡 Nvidia's earnings report that was published exceeded expectations so that Nvidia was able to make $26 billion in profits in the first 3 months of this year, which is really great. 💡Profitability was 5.3% higher than forecasts , and Nvidia made a profit of $6.12 Earnings per Share(EPS) . 💡Nvidia forecasted $28 billion in revenue for the fiscal second quarter , with a margin of error of 2% . 💡Soon the price of each stock will be divided into 10 units. For each stock of the price break, $0.01 is distributed, which represents 150% growth from the previous period. 💡 Artificial Intelligence Tokens have not yet shown their progress, but it is better to keep an eye on them. BINANCE:FETUSDT _ BINANCE:NEARUSDT _ BINANCE:RNDRUSDT _ BINANCE:GRTUSDT _ BINANCE:TAOUSDT _ BINANCE:INJUSDT _ BINANCE:THETAUSDT -------------------------------------------------------------------------------------------- 📊Now let's take a look at the NVIDIA chart . ✅ NVIDIA managed to break the 🔴 Resistance zone($974_$924) 🔴 by Breakaway Gap . 📈In terms of Classic Technical Analysis , NVIDIA has managed to form a Bullish Long Island Pattern , and this pattern is one of the continuing patterns and will be a sign of the continuation of NVIDIA's upward trend . 🌊According to the theory of Elliott Waves , NVIDIA is completing the main wave 5 and it is very likely that the main wave 5 will finish in the 🟡 Potential Reversal Zone(PRZ)($1,305_$1,138) 🟡. 🔔I expect that NVIDIA will continue to grow at least 🚀➕20%🚀 more, although minor corrections are also possible. NVIDIA Analyze (NVDAUSD), Daily time frame ⏰. Do not forget to put Stop loss for your positions (For every position you want to open). Please follow your strategy; this is just my Idea, and I will gladly see your ideas in this post. Please do not forget the ✅' like '✅ button 🙏😊 & Share it with your friends; thanks, and Trade safe.
NASDAQ:NVDALong
by pejman_zwin
1
Taiwan Semiconductor - Unknown stock with trading potentialNYSE:TSM is one of the rather unknown stocks with an impressive market capitalization of 680 billion dollars. Just a couple of months ago TSM finally broke above a major previous resistance level and confirmed the bullish triangle breakout. Momentum is quite strong so far so maybe we will never see the previous structure again. In this case there is no need to actually chase the all time high. However, a pullback might still be quite likely and this might present an interesting long opportunity in the future. Levels to watch: $130, $100 Keep your long term vision, Philip - BasicTrading
NYSE:TSMLong
by basictradingtv
6
APPLE (AAPL)Apple's innovation shown in iPhone 14 is not likely enough to entice consumers to stretch their budgets in the current macroeconomic environment 40% of Warren Buffett portfolio still belongs to Apple?! for most people and traders I think its a slow asset class and like Tim Apple! sorry Cook ,Warren like to play safe too Apple price showed a good reaction to 135 support and now heading to 149, for Scalpers breaking 150 resistance can be a good long opportunity and for investors AAPL still can back to 125$ levels so there is no reason to fomo
NASDAQ:AAPLLong
by moonypto
2
Intel Corporation | INTCIntel reported second quarter earnings on Thursday, showing a return to profitability after two straight quarters of losses and issuing a stronger-than-expected forecast. the stock rose 7% in extended trading. Here’s how Intel did versus Refinitiv consensus expectations for the quarter ended July 1: Earnings per share: 13 cents, adjusted, versus a loss of 3 cents expected by Refinitiv. Revenue: $12.9 billion, versus $12.13 billion expected by Refinitiv. For the third quarter, Intel expects earnings of 20 cents per share, adjusted, on revenue of $13.4 billion at the midpoint, versus analyst expectations of 16 cents per share on $13.23 billion in sales. Intel posted net income of $1.5 billion, or 35 cents per share, versus a net loss of $454 million, or a loss of 11 cents per share, in the same quarter last year. Revenue fell 15% to $12.9 billion from $15.3 billion a year ago, marking the sixth consecutive quarter of declining sales. Intel CEO Pat Gelsinger said on a call with analysts the company still sees “persistent weakness” in all segments of its business through year-end, and that server chip sales won’t recover until the fourth quarter. He also said that cloud companies were focusing more on securing graphics processors for artificial intelligence instead of Intel’s central processors. David Zinsner, Intel’s finance chief, said in a statement that part of the reason the report was stronger than expected was because of the progress the company has made toward slashing $3 billion in costs this year. Earlier this year, Intel slashed its dividend and announced plans to save $10 billion per year by 2025, including through layoffs. “We have now exited nine lines of business since Gelsinger rejoined the company, with a combined annual savings of more than $1.7 billion,” said Zinsner. Revenue in Intel’s Client Computing group, which includes the company’s laptop and desktop processor shipments, fell 12% to $6.8 billion. The overall PC market has been slumping for over a year. Intel’s server chip division, which is reported as Data Center and AI, saw sales decline 15% to $4 billion plus Intel’s Network and Edge division, which sells networking products for telecommunications, recorded a 38% decline in revenue to $1.4 billion.moreover Mobileye, a publicly traded Intel subsidiary focusing on self-driving cars, saw sales slip 1% on an annual basis to $454 million and Intel Foundry Services, the business that makes chips for other companies, reported $232 million in revenue. Intel’s gross margin was nearly 40% on an adjusted basis, topping the company’s previous forecast of 37.5%. Investors want to see gross margins expand even as the company invests heavily in manufacturing capability. In the first quarter, the company posted its largest loss ever as the PC and server markets slumped and demand declined for its central processors. Intel’s results on Thursday beat the forecast that management gave for the second quarter at the time. Intel management has said the turnaround will take time and that the company is aiming to match TSMC’s chip-manufacturing prowess by 2026, which would enable it to bid to make the most advanced mobile processors for other companies, a strategy the company calls “five nodes in four years.” Intel said on Thursday that it remained on track to hit those goals. Nvidia has had an amazing run, but any emerging technology, such as AI, which is bottlenecked by a single company will have issues in growth. Consulting firm McKinsey has pegged the AI market to be worth $1 trillion by 2030, but also that it was in an experimental and in early phases of commercial deployment. While Nvidia will likely retain its leadership in GPU hardware as applied to AI for the foreseeable future, it is likely that other hardware solutions for AI systems will also be successful as AI matures. While technologist may quibble on specifics, all major AI hardware today are based on GPU architectures, and as such I will use the terms and concepts of AI hardware and GPU architecture somewhat interchangeably. One likely candidate for AI related growth may be AMD (AMD), which has had GPU products since acquiring ATI in 2006.However, unlike Nvidia, which had a clear vision for of general-purpose GPU products (GPGPU), historically, AMD had largely kept its focus on the traditional gaming applications. AMD has developed an AI architecture called XDNA, and an AI accelerator called Alveo and announced its MI300, an integrated chip with GPU acceleration for high-performance computing and machine learning. How AMD can and may evolve in the AI may be subject of a different article. Another contender for success in the AI applications using GPU is Intel, who is the focus of this article. Intel has maintained a consistent, if low key focus on GPU hardware focused on AI applications over the last decade. Intel’s integrated HD Graphics is built into most modern processor ICs; however, these are insufficient compared to dedicated GPUs for high-end inferencing or machine learning tasks. It has 2 primary GPU architectures in production release: In 2019 Intel Corporation acquired Habana Labs, an Israel-based developer of programmable deep learning accelerators for the data center for approximately $2 billion. Habana Labs’ Gaudi AI product line from its inception focused on AI deep learning processor technologies, rather than as GPU that has been extended to AI applications. As a result, Gaudi microarchitecture was designed from the start for the acceleration of training and inferencing. In 2022 Intel announced Gaudi2 and Greco processors for AI deep learning applications, implemented in 7-nanometer (TSMC) technology and manufactured on Habana’s high-efficiency architecture. Habana Labs benchmarked Gaudi2’s training throughput performance for the ResNet-50 computer vision model and the BERT natural language processing model delivering twice the training throughput over the Nvidia high end A100-80GB GPU. So, Gaudi appears to give Intel a competitive chip for AI applications. Concurrent with the Habana Labs’ Gaudi development, Intel has internally developed the Xe GPU family, as dedicated graphics card to address high-end inferencing or machine learning tasks as well as more traditional high-end gaming. Iris® Xe GPU family consists of a series of microarchitectures, ranging from integrated/low power (Xe-LP) to enthusiast/high performance gaming (Xe-HPG), data center/AI (Xe-HP) and high-performance computing (Xe-HPC). The architecture has been commercialized in Intel® Data Center GPU Flex Series (formerly codenamed Arctic Sound) and Intel® Arc GPU cards. There is some question on Xe GPU future and evolution. Intel has shown less commitment to the traditional GPU space compared to Gaudi. Nonetheless, it does demonstrate Intel ability to design and field complex GPU products as its business requires. Intel has many other AI projects underway. The Sapphire Rapids chips implements AI specific acceleration blocks including technology called AMX (Advanced Matrix Extensions), which provides acceleration inside the CPU for efficient matrix multiplications used in on-chip inferencing and machine learning processing by speeding up data movement and compression. Intel has supporting technologies such as Optane, which while cancelled as a production line, is available for their needs of a high-performance non-volatile memory, one of the intrinsic components in any AI product. Based on the above, Intel appears to have competitive hardware solutions, however if we look at Nvidia success in AI, it is a result of a much a software and systems focus as it is the GPGPU hardware itself. Can Intel compete on that front. Ignoring for the moment that Intel has a huge software engineer (approx. 15,000) resource, it also has- access to one of the leading success stories in perhaps the most competitive AI application – self driving cars. Mobileye, who was acquired by Intel in 2017, has been an early adopter and leader, with over 20 years of experience in automotive automated driving and vision systems. As such, Mobileye has a deep resource of AI domain information that should be relevant to many applications. Mobileye has announced that it is working closely with Habana, as related divisions within Intel. While Intel is in the process of re-spinning out Mobileye as public company, Mobileye Global Inc. (MBLY), at present Intel still owns over 95% of shares, keeping it effectively an Intel division. In looking at Intel, we have a company with the history, resources, and technology to compete with Nvidia and infrastructure. They have made significant investment and commitment to the emerging AI market, in times when they have exited other profitable businesses. It should also be understood that AI related product are a small percentage of overall Intel revenues (INTC revenue are more than twice NVDA, even if NVDA has 6x its market cap), and continues to keep its primary business focus on its processor and foundry business. Hopefully for shareholders, Intel continues to push their AI technology and business efforts. Their current position is that this is strategic, but Intel is in a very fluid time and priorities may change based on business, finances, and of course the general interest and enthusiasm for AI. It is always worth noting that AI as a technical concept is mature, and appears to be cyclical, with interest in the technical community rising and falling in hype and interest once every decade or so. I remember working on AI applications, at the time labeled as expert systems in the 1980s. If we are currently at a high hype point, this may be temporary, based on near term success and disappointment in what AI does achieve. Of course, as always, “this time is different” and the building blocks of effective AI systems currently exist, where for previous iterations, it was more speculative.
NASDAQ:INTC
by moonypto
4
Intel - Reversing to the upside!Hello Traders and Investors, today I will take a look at Intel . -------- Explanation of my video analysis: On the chart of Intel there are actually two major horizontal structure levels which you have to keep an eye on. First of all there is quite strong support at the $26 level and just a couple of months ago Intel rejected this support towards the upside. Vice versa there is resistance at the $44 level, always pushing price lower. As we are speaking Intel is also retesting a minor support so there is the chance to capitalize on a short term bounce. -------- Keep your long term vision, Philip (BasicTrading)
NASDAQ:INTCLong
by basictradingtv
1
GE HealthCare | GEHCGE Healthcare aka GEHC is a renowned global medical technology, pharmaceutical diagnostics, and digital solutions company that aims to revolutionize healthcare by eliminating limits. With a diverse portfolio of innovative products, services, and solutions, GEHC empowers healthcare professionals to make informed decisions quickly and improve patient care across the entire healthcare continuum. This article delves into the key aspects of GE Healthcare, including its business segments, macro trends driving growth, management incentives, financial performance, competitors, and valuation. GE Healthcare operates in four business segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. These segments cater to healthcare providers and researchers worldwide, offering a wide range of products and solutions that enhance clinical decision-making and patient outcomes. The company's revenue streams come from the sale of medical devices, consumable products, services, and digital solutions. By focusing on customer-driven innovation, industry-leading service capabilities, and integrated digital solutions, GEHC continually improves the performance, quality, and customer experience of its offerings. GE Healthcare benefits from several macro trends that are shaping the healthcare industry. The growing adoption of precision health, fueled by advancements in genomics, personalized medicine, and targeted therapies, presents opportunities for GEHC to develop tailored solutions. The global precision medicine market is projected to reach $278.3 billion by 2027, with a CAGR of 10.5%. Additionally, the market for genomic testing is expected to reach $30.9 billion by 2027, growing at a CAGR of 14.7%. The digitization of healthcare through AI and machine learning enables the analysis of vast amounts of patient data for more accurate diagnoses and treatment decisions. The global healthcare artificial intelligence market is predicted to reach $31.3 billion by 2025, growing at a CAGR of 41.5%. Furthermore, increasing demand for healthcare services driven by demographic trends and improving access to healthcare in emerging markets further support GEHC's growth trajectory. With personalized medicine estimated to have a market value of $3,168.0 billion by 2027, GEHC is well positioned to leverage these trends and provide innovative solutions to meet the evolving needs of the healthcare industry (Sources: Grand View Research, Fortune Business Insights, Allied Market Research, MarketsandMarkets). GEHC CEO, Peter J. Arduini, has improved incentives in place to drive the company's performance. With an amended offer letter, Arduini's base salary increased to $1,250,000, accompanied by an annual target bonus of 150% of his base salary and an annual long-term incentive grant target of $11,875,000 starting in 2023. These incentives provide a strong motivation for Arduini to lead GEHC's growth and success, enhancing shareholder value. In 2022, GEHC reported total revenue of $18.34 billion, representing a favorable increase compared to the previous year. Although the profitability declined in the final quarter, the company's operating cash flow and adjusted EBIT margin showed positive trends. GEHC guided organic revenue growth of 5% to 7% for 2023, along with higher adjusted EBIT margin and EPS ranges. The company's commitment to achieving a free cash flow conversion target of 85% or more further reinforces its positive financial outlook. GEHC faces competition from prominent players in the medical technology industry, including Philips Healthcare, Draeger, Mindray, Masimo, and Baxter. In specific segments, GEHC competes with Siemens Healthineers, Canon, Fujifilm, Carestream, Hologic, and other companies. Despite competition, GEHC's comprehensive product portfolio, customer-focused approach, and commitment to innovation position it well in the market. GE Healthcare stands out from its competitors in the healthcare sector due to its robust portfolio of cutting-edge products and data-driven solutions. The company's commitment to innovation and advanced technologies enables it to offer unique offerings that address the evolving needs of the industry. One key area where GEHC excels is precision health. Leveraging advancements in genomics, personalized medicine, and targeted therapies, GEHC develops tailored solutions that provide precise and effective treatments for patients. For example, its innovative imaging technologies, such as magnetic resonance imaging (MRI) and computed tomography (CT), enable high-resolution visualization of anatomical structures, aiding in the accurate diagnosis and monitoring of various medical conditions. Moreover, GEHC is at the forefront of the digital revolution in healthcare. By harnessing the power of artificial intelligence (AI) and machine learning, GEHC's products analyze vast amounts of patient data to deliver more accurate diagnoses and treatment decisions. For instance, its AI-powered imaging software can detect and analyze anomalies in medical images, helping clinicians detect diseases at an early stage and enhance treatment outcomes. This data-driven approach not only improves patient care but also increases operational efficiency in healthcare facilities. GEHC's commitment to delivering innovative solutions is further reflected in its diverse product offerings. The company provides a wide range of medical devices, including ultrasound systems, patient monitors, anesthesia machines, and diagnostic imaging equipment. These products are designed to meet the unique needs of healthcare providers and patients, empowering clinicians to make informed decisions and improving patient outcomes. Based on a valuation analysis using trading multiples of similar companies, GEHC's value is estimated to range from $55 billion to $81 billion. Taking the midpoint of this range, the company's estimated enterprise value (EV) is $64 billion, suggesting a potential stock price of $125. This valuation indicates a significant upside potential of at least 66% within 18 to 24 months from the current price. With its strong market position, growth opportunities, and commitment to advancing healthcare, GEHC presents an attractive investment prospect. GE Healthcare is a leading global medical technology and digital solutions company with a clear mission to transform healthcare. With its diverse portfolio of products, services, and solutions, GEHC is well-positioned to capitalize on the growing demand for precision health, digitization, and improved access to healthcare. The company's financial performance, management incentives, and competitive landscape further support its growth potential. Considering the estimated valuation, GE Healthcare's stock price has the potential to increase significantly in the next 1.5 to 2 years, offering investors an opportunity for substantial returns.
NASDAQ:GEHCLong
by moonypto
COINBASE Can catapult above $300 any time.Coinbase Global (COIN) has been trading within a long-term Channel Up pattern since the October 27 2023 bottom. Its long-term Support level is the 4H MA200 (orange trend-line) which was most recently tested on May 14 2024 and held. Just like the February 07 (near) test, this is technically the latest Higher Low of the Channel Up. The break-out above the Falling Wedge that followed, similar to the February bottom, has found Support on the 4H MA50 (blue trend-line), which held even during Friday's dramatic pull-back. With the Sine Waves accurately depicting COIN's all recent bottoms (Higher Lows) and tops (Higher Highs), they clearly show that we are past the latest bottom and have already started the new Bullish Leg to a Higher High. The previous one was priced just above the 1.786 Fibonacci extension level. As a result, we remain bullish on this stock, setting a new price Target at $380.00 (Fib 1.786), which can be achieved by mid-July. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NASDAQ:COINLong
by TradingShot
GAMESTOP Will the meme stock have another gap up tomorrow?GameStop Corporation (GME) had a massive +75% opening today, product of 'Roaring Kitty' latest news, but corrected from $40 to sub $30 intra day. We saw a similar pattern during GME's previous rally on May 13, with a 1st Gap Up that was followed by a 2nd that eventually formed the 64.90 Resistance. Both sequences started off with a Higher Lows rise and identical 1D RSI patterns. It appears we are currently on Gap Up 1 and the late session consolidation may give way tomorrow to an equally impressive Gap up to test 64.90. Of course never forget with such kind of stocks and high importance after of pre-market news can drastically alter the technicals. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NYSE:GMELong
by TradingShot
1
Spy continues to near its target of 570 before U.S. electionsWith the dollar trending down and the VIX at low levels, we can then continue to expect the U.S. stock market to continue to rise. And, in fact, that is what we are witnessing as we close in on the blow-off top target of the Elliot Wave theory that has resonated with my instincts for these last 2 and a half years. We are currently in wave 5 and on our way to the target I have set of SPY 570-600. There is still time and I believe we will easily get there before U.S. election shenanigans begin to unfold (see my post on the VIX). Once you start to catch wind of anomalous election news events here in the U.S., know that we are near our top. For me, it will be time to pull out.
AMEX:SPYLong
by stewdamus
NIFTY 660+ Points GainAfter a massive week of 660+ points gain, NIFTY has given a SHORT opportunity yesterday. Days of volatility, guys! BIG money. Everybody is talking about the co-relation of election results. And why not, market being driven by fundamentals in full power and josh. A big move is still pending, I dont know if thats gonna happen on Monday 3rd June, 4th June or 5th June. There is a possibility of big gap-ups and gap-downs on these days, specifically. So, BTST traders, you better watch out and be careful. Risk management is key. Also, position sizing needs to be watched. You would not want to go in big with a hope to capture big move, only to witness a rude reversal. NO POSITION IS ALSO A POSITION! So, be careful, and enjoy the fireworks, gonna start any time now.
NSE:NIFTY
by ProfitsNinja
ROCKET LAB Bullish break-out imminent.Rocket Lab USA (RKLB) has completed a Bull Flag pattern (green Channel), trading right below the 1D MA200 (orange trend-line), which has been its long-term Resistance since January 24 2024. Based on its 2-year Cyclical pattern, the stock should surge aggressively if it breaks above the 1D MA200. The 1D RSI is posting the exact same formation it had during the break-outs of May 2023 and July 2022. All formed after strong rebounds within the Support Zone. In any case, our medium-term Target $5.50, which will be a test of the Lower Highs trend-line, similar to June 07 2023. ------------------------------------------------------------------------------- ** Please LIKE 👍, FOLLOW ✅, SHARE 🙌 and COMMENT ✍ if you enjoy this idea! Also share your ideas and charts in the comments section below! This is best way to keep it relevant, support us, keep the content here free and allow the idea to reach as many people as possible. ** ------------------------------------------------------------------------------- 💸💸💸💸💸💸 👇 👇 👇 👇 👇 👇
NASDAQ:RKLBLong
by TradingShot
Colgate can shine your portfolio and Teeth. Colgate-Palmolive (India) Limited is an MNC India's leading provider of scientifically proven oral care products. The range includes toothpastes, toothpowder, toothbrushes and mouthwashes under the 'Colgate' brand, as well as a specialized range of dental therapies under the banner of Colgate Oral Pharmaceuticals. The Company is engaged in manufacturing/ trading of toothpaste, tooth powder, toothbrush, mouthwash and personal care products. It also provides a range of personal care products under the `Palmolive' brand name. The positive aspects of the company are Company with No Debt, Mutual Funds Increased Shareholding in Past Month, Company with Zero Promoter Pledge and MFs increased their shareholding last quarter. The Negative aspects of the company are High P.E. Ratio=55.5, RSI indicating price weakness and Recent Broker Downgrades in Reco or Target Price. Entry can be taken after closing above 2709. Targets in the stock will be 2735, 2765 and 2827. The long-term target in the stock will be 2877, 2920 and 2961. Stop loss in the stock should be maintained at Closing below 2642. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:COLPALLong
by Happy_Candles_Investment
Aarti Drugs giving signs of pennant Breakout. Aarti Drugs Limited (ADL) is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. ADL engages in the development, manufacture and market of pharmaceutical products. The firm operates through the Out of India, and India geographical segments. Aarti Drugs Limited (ADL) CMP is 495.70. The positive aspects of the company are Company with Low Debt, Growth in Quarterly Net Profit with increasing Profit Margin, Company with Zero Promoter Pledge, FII / FPI or Institutions increasing their shareholding, and Mutual Funds Increased Shareholding. The Negative aspects of the company are Decline in Quarterly Net Profit, MFs decreased their shareholding last quarter and Promoter decreasing their shareholding. Entry can be taken after closing above 503 Targets in the stock will be 519 and 531. The long-term target in the stock will be 549 and 568. Stop loss in the stock should be maintained at Closing below 456. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:AARTIDRUGSLong
by Happy_Candles_Investment